BeOne Medicines (ONC) Assets (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.46% |
| Dec 31, 2025 | 7.28% |
| Sep 30, 2025 | 21.18% |
| Jun 30, 2025 | 7.82% |
| Mar 31, 2025 | -1.34% |
| Dec 31, 2024 | 1.54% |
| Sep 30, 2024 | 2.08% |
| Jun 30, 2024 | 0.79% |
| Mar 31, 2024 | -2.37% |
| Dec 31, 2023 | 5.08% |
| Sep 30, 2023 | -3.56% |
| Jun 30, 2023 | -3.83% |
| Mar 31, 2023 | 8.68% |
| Dec 31, 2022 | -18.51% |
| Sep 30, 2022 | -8.84% |
| Jun 30, 2022 | -8.02% |
| Mar 31, 2022 | -6.02% |
| Dec 31, 2021 | 61.46% |
| Sep 30, 2021 | -4.30% |
| Jun 30, 2021 | -5.10% |
| Mar 31, 2021 | 3.93% |
| Dec 31, 2020 | 0.62% |
| Sep 30, 2020 | 42.61% |
| Jun 30, 2020 | -4.03% |
| Mar 31, 2020 | 152.26% |
| Dec 31, 2019 | -14.29% |
| Sep 30, 2019 | -12.52% |
| Jun 30, 2019 | -1.01% |
| Mar 31, 2019 | -3.44% |
| Dec 31, 2018 | -6.60% |
| Sep 30, 2018 | 45.64% |
| Jun 30, 2018 | -3.22% |
| Mar 31, 2018 | 63.30% |
| Dec 31, 2017 | -0.25% |
| Sep 30, 2017 | 121.33% |
| Jun 30, 2017 | 25.81% |
| Mar 31, 2017 | -7.17% |
| Dec 31, 2016 | 72.37% |
| Sep 30, 2016 | -6.29% |
| Jun 30, 2016 | -5.28% |
| Mar 31, 2016 | 127.15% |